Sage Journals: Discover world-class research

Free access

Research article

First published 2023-8

Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma

Ismail Beypınar, Yıldız Sözel, Arif Hakan Önder

Cancer Biomarkers

Open access

Research article

First published 2025

Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials

Albert Jang, Jeffrey Y. Zhong, Hamsa L.S. Kumar [...]

Kidney Cancer

Retricted access

Research article

First published 2023-5

Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters

Rukiye Arikan, Salih Ozguven, Tugba Akin Telli [...]

Acta Radiologica

Open access

Research article

First published 2022

Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib

Sara Elena Rebuzzi, Luigi Cerbone, Alessio Signori [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022-11-18

Logical Imputation to Optimize Prognostic Risk Classification in Metastatic Renal Cell Cancer

Jake S.F. Maurits, Loes F.M. van der Zanden, Meta H.M. Diekstra [...]

Kidney Cancer

Open access

Research article

First published 2021

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)

Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2018-3-30

Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC) 1

Igor Stukalin, J. Connor Wells, Anna Fraccon [...]

Kidney Cancer

Open access

Research article

First published 2017-7-26

Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)

Steven M. Yip, Jose M. Ruiz Morales, Frede Donskov [...]

Kidney Cancer

Retricted access

Review article

First published 2018-3

Real-world evidence in metastatic renal cell carcinoma

Jeffrey Graham, Daniel YC Heng

Tumori Journal

Open access

Research article

First published 2022

Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life,population-based Austrian study comprising three decades of follow-up

Hannah Fluhrer, Georg C. Hutterer, Sylvia Golbeck [...]

Therapeutic Advances in Medical Oncology

Search results